• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子干扰RNA和反义寡核苷酸的皮肤/透皮递送——进展与障碍

Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles.

作者信息

Ita Kevin

机构信息

College of Pharmacy, Touro University, Mare Island-Vallejo, CA 94592, USA.

出版信息

Biomed Pharmacother. 2017 Mar;87:311-320. doi: 10.1016/j.biopha.2016.12.118. Epub 2017 Jan 5.

DOI:10.1016/j.biopha.2016.12.118
PMID:28064104
Abstract

A diverse array of nucleic acids has been studied by several researchers for the management of several diseases. Among these compounds, small interfering RNA and antisense oligonucleotides have attracted considerable attention. Antisense oligonucleotides are synthetic single stranded strings of nucleic acids that bind to RNA and thereby alter or reduce expression of the target RNA while siRNAs, on the other hand, are double-stranded RNA molecules which can hybridize with a specific mRNA sequence and block the translation of numerous genes. One of the main obstacles in the dermal or transdermal delivery of these compounds is their low skin permeability. In this review, various techniques used to enhance the delivery of these molecules into or across the skin are described and in some cases, the correlation between enhanced dermal/transdermal delivery and therapeutic efficacy is highlighted.

摘要

几位研究人员对多种核酸进行了研究,以用于多种疾病的治疗。在这些化合物中,小干扰RNA和反义寡核苷酸引起了相当大的关注。反义寡核苷酸是合成的单链核酸,可与RNA结合,从而改变或降低靶RNA的表达,而小干扰RNA则是双链RNA分子,可与特定的mRNA序列杂交并阻断众多基因的翻译。这些化合物经皮给药的主要障碍之一是其皮肤渗透性低。在这篇综述中,描述了用于增强这些分子进入皮肤或透过皮肤递送的各种技术,并且在某些情况下,强调了增强的经皮/透皮递送与治疗效果之间的相关性。

相似文献

1
Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles.小分子干扰RNA和反义寡核苷酸的皮肤/透皮递送——进展与障碍
Biomed Pharmacother. 2017 Mar;87:311-320. doi: 10.1016/j.biopha.2016.12.118. Epub 2017 Jan 5.
2
Topical and transdermal delivery of antisense oligonucleotides.反义寡核苷酸的局部和经皮递送
Curr Opin Mol Ther. 2001 Jun;3(3):244-8.
3
Transdermal iontophoretic drug delivery: advances and challenges.经皮离子电渗药物递送:进展与挑战。
J Drug Target. 2016;24(5):386-91. doi: 10.3109/1061186X.2015.1090442. Epub 2015 Sep 25.
4
Intradermal delivery of antisense oligonucleotides by the pulse depolarization iontophoretic system.通过脉冲去极化离子电渗系统进行反义寡核苷酸的皮内递送。
Biol Pharm Bull. 2003 Oct;26(10):1461-6. doi: 10.1248/bpb.26.1461.
5
Oral delivery of siRNA and antisense oligonucleotides.小干扰RNA和反义寡核苷酸的口服递送。
J Drug Target. 2009 Aug;17(7):491-5. doi: 10.1080/10611860903057674.
6
Nucleic acid delivery for therapeutic applications.治疗应用的核酸递送。
Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4.
7
Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA.核酸的眼部递送:反义寡核苷酸、适配体和小干扰RNA
Adv Drug Deliv Rev. 2006 Nov 15;58(11):1203-23. doi: 10.1016/j.addr.2006.07.020. Epub 2006 Sep 15.
8
State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.聚合物纳米载体递送反义寡核苷酸和小干扰RNA的研究现状与展望
Int J Pharm. 2008 Dec 8;364(2):237-48. doi: 10.1016/j.ijpharm.2008.06.011. Epub 2008 Jun 19.
9
Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System.用于递送反义寡核苷酸和小干扰 RNA 的(纳米)制剂设计的进展:聚焦于中枢神经系统。
Mol Pharm. 2021 Apr 5;18(4):1491-1506. doi: 10.1021/acs.molpharmaceut.0c01238. Epub 2021 Mar 18.
10
Irontophoresis: transdermal delivery of iron by iontophoresis.电离子导入:通过电离子导入经皮递送铁。
J Pharm Sci. 2009 Aug;98(8):2670-6. doi: 10.1002/jps.21641.

引用本文的文献

1
Advances in transdermal siRNAs delivery: A review of current research progress.经皮递送小干扰RNA的研究进展:当前研究进展综述
Noncoding RNA Res. 2023 May 26;8(3):392-400. doi: 10.1016/j.ncrna.2023.05.008. eCollection 2023 Sep.
2
Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs.了解核酸和基因药物的体内命运以进行药物的合理设计。
Pharmaceutics. 2021 Jan 26;13(2):159. doi: 10.3390/pharmaceutics13020159.
3
Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress.
经皮给药离子导入的影响因素及药物应用:最新进展概述。
Drug Deliv Transl Res. 2022 Jan;12(1):15-26. doi: 10.1007/s13346-021-00898-6. Epub 2021 Jan 23.
4
Fractional Laser-Mediated siRNA Delivery for Mitigating Psoriasis-like Lesions via IL-6 Silencing.通过IL-6沉默实现分数激光介导的siRNA递送以减轻银屑病样病变
Mol Ther Nucleic Acids. 2020 Mar 6;19:240-251. doi: 10.1016/j.omtn.2019.11.013. Epub 2019 Nov 20.
5
Is the Fractional Laser Still Effective in Assisting Cutaneous Macromolecule Delivery in Barrier-Deficient Skin? Psoriasis and Atopic Dermatitis as the Disease Models.在皮肤屏障缺陷的皮肤中, 激光是否仍然有效辅助大分子药物透皮吸收?以银屑病和特应性皮炎为疾病模型。
Pharm Res. 2018 Apr 26;35(7):128. doi: 10.1007/s11095-018-2413-6.